The outer membrane protein OspB of Borrelia burgdorferi, the Lyme borreliosis agent, differs in relative molecular weight (Mr) among strains. To determine whether antigenic variation occurs in B. burgdorferi, a cell population of the human isolate HB19 was cloned first by being diluted in broth and then by being plated on agar medium. Several clones were obtained and characterized by polyacrylamide gel electrophoresis, in situ protease treatment, and Western (immunoblot), Southern, and Northern (RNA) 
Lyme borreliosis is a common tick-transmitted zoonosis of temperate latitudes of North America, Europe, and Asia (reviewed in reference 6). Infection with the spirochete Borrelia burgdorferi is the proximate cause of the disorder (12, 14, 27) . Some infected persons recover uneventfully after an acute illness, while others suffer a disorder that may progress through three stages in a course measured in years (26, 28) . Patients with late disease present with chronic arthritis or disabling dysfunctions of the nervous system. Despite vigorous humoral and cellular immune responses by the host to the agent, the spirochete is able to persist for years in these patients (26) . The mechanisms by which B. burgdorferi avoids elimination by the immune system of the host are unknown.
Immunological and biochemical analyses have revealed differences between B. burgdorferi isolates from North America and Europe (7, 30) . In large measure, serotypic distinctions are attributable to differences in abundant outer surface proteins that have been designated Osp proteins. The type strain B31 and the majority of other North American isolates of B. burgdorferi have two Osp proteins, A and B, with relative molecular weights (Mr) of approximately 31,000 and 34,000 (31K and 34K proteins), respectively (9, 11) . In a collection of North American isolates, OspB proteins were more heterogeneous than OspA with respect to size and reactivity with monoclonal antibodies (7) (8) (9) . In strain B31, ospA and ospB, the genes for the two Osp proteins, are tandemly arrayed on linear plasmids and cotranscribed (13, 18, 19) .
One explanation for the persistence of bacteria in the host is antigenic variation by the pathogen. This strategy is used by the closely related borrelia, B. hermsii, an agent of relapsing fever (10) . Antigenic differences between strains in B. burgdorferi were documented as reviewed above (7-9, 11, * Corresponding author. 30 ). There was also evidence of antigenic variation within a strain of B. blurgdorferi. During infections in rabbits, cotton rats, gerbils, and mice, spirochete numbers in the blood of the animals fluctuated (15, 16, 25) . There were alternating periods during which borreliae were or were not cultivable from the blood of cotton rats (K. Gage, W. Burgdorfer, and A. G. Barbour, unpublished observations). During in vitro cultivation of B. burgdorferi, changes in the presence, apparent size, and antibody reactivity of the OspB protein were noted (23, 24) . In a study of human disease, Craft et al. found that some patients with Lyme borreliosis exhibited the new appearance of OspB-specific immunoglobulin M (IgM) antibodies a year or more after infection (17) .
The foregoing reports indicated that the OspB protein may play an important role in evasion of the immune response by the pathogen. To determine whether true antigenic variation in this protein occurs and to characterize any changes in OspB, we examined the progeny of single organisms grown in vitro. Previous studies had employed what were possibly mixed populations of B. burgdorferi (15, 16, (23) (24) (25) . The experiments described herein demonstrate that B. burgdorferi is polymorphic with respect to the OspB protein.
MATERIALS AND METHODS
Spirochete strains. B. burgdorferi strains were B31 (ATCC 35210), the type strain, and HB19, a blood isolate from a patient with Lyme disease in Connecticut (9, 27) . Both strains had been cloned twice by limiting dilution (4). The two strains were distinguished by their reactivities with monoclonal antibodies (8, 9) and by their plasmid profiles 2734 BUNDOC AND BARBOUR (12,000 x g for 12 min at 20°C) when there were approximately 108 spirochetes per ml.
A solid medium based upon BSK II was also prepared by using a modification of the method of Kurtii et al. (20) . To 400 ml of deionized water was added the following: 100 ml of 1Ox CMRL 1066 concentrate without glutamine ( Variant isolation. For cloning by limiting dilution, late log phase broth cultures (108 spirochetes per ml) were serially diluted 10-fold from 10-2 to 10-10. One 10-ml tube was used for dilutions of 10-2 to 10-6, two were used for dilutions of 10-7, and ten were used for dilutions of 10-8 to (16) . Cloning of hybridomas, PAGE analysis of light chains for confirmation of antibody purity, and isotype determinations were carried out as described previously (9) (10) (11) . Protease treatment. Intact spirochetes were treated with trypsin essentially as described previously (9 8 .0], 50 mM EDTA, 15% sucrose). The suspension was cooled on ice for 10 min before adding 250 pL of 1% sodium deoxycholate (Sigma) in TES and 6 pL of diethylpyrocarbonate (Sigma). After the sample had been shaken for 10 min, 250 pL of 7.5 M ammonium acetate was added and the samples were centrifuged at 12,000 x g for 10 min. The plasmid DNA was precipitated from the supernatant fluid by the addition of an equal volume of cold isopropanol. The precipitate was recovered by centrifugation (12 ,000 x g for 25 min) and dissolved in 10 mM Tris (pH 8.0)-i mM EDTA.
The procedure for Southern blot analysis was essentially as described previously (7) supplier. Fragments were separated in a 1% agarose gel and then were transferred to nylon membranes (Biotrans; 1.2-p.m pore; ICN Biomedicals, Irvine, Calif.). The prehybridization and hybridization solutions were composed of 50% formamide-5x Denhardt-6x SSC (lx SSC is 0.15 M NaCl and 0.015 M sodium citrate)-5 mM EDTA-0.5% sodium dodecyl sulfate-0.1% sodium pyrophosphate-0.01% salmon sperm DNA (5). Hybridization procedures were performed at 37°C, and washes with 0.1x SSC-0.1% sodium dodecyl sulfate-1 mM EDTA were carried out at 64°C. The filters were placed on X-ray film with an intensifying screen at -79°C.
RNA extraction and Northern (RNA) blot analysis. Total RNA was extracted from freshly harvested borreliae and subjected to Northern blot analysis as described previously (18, 29) . The cell lysing solution was 4 M guanidine thiocyanate-25 mM sodium citrate (pH 7.0)-2% 2-mercaptoethanol-2% sodium lauryl sarcosinate. RNA was stored in 70% ethanol at -20°C until electrophoresis, at which time it was recovered by centrifugation, dried, and suspended in diethylpyrocarbonate-treated water and sample buffer (18) . The electrophoresis buffer for 1.2% agarose gels was 2.2 M formaldehyde-200 mM HEPES-sodium salt (pH 7.0)-S50 mM sodium acetate-10 mM EDTA. Electrophoresis was at 2 V/cm for 15 h. The gel was stained with acridine orange to visualize the 23S, 16S, and 5S rRNA bands (21) . The fractionated RNA was transferred to a nylon membrane. The prehybridization, hybridization, and washing procedures were the same as described for Southern blot analysis.
RESULTS
Cloning by limiting dilution. Strain HB19 of B. burgdorferi was originally recovered from the blood of a patient with first-stage Lyme borreliosis in 1982 (9, 27) . It had been passed in broth medium continuously for 3 years and had been cloned by limiting dilution twice during that period. HB19 was chosen for study of possible antigenic variation because it had been observed to vary in the Mr of its OspB protein during the course of serial passage (unpublished observations). In addition, HB19 did not aggregate; 95% or more of the cells examined by phase-contrast microscopy occurred singly. Thus, cloning by limiting dilution was a feasible technique for isolating clonal populations of B. burgdorferi. Monoclonal antibody H5TS was known to recognize the OspB protein of HB19 (8, 9) . To further define possible antigenic changes, additional murine monoclonal antibodies to the OspB protein of HB19 were sought. Three different IgG antibodies were found to bind to the OspB protein of HB19 in Western blots and were designated H68, H614, and H63.
A culture of HB19 that had been passaged continuously for 3 months (or approximately 600 generations) after the last cloning by limiting dilution was examined by PAGE. We noted that the band corresponding to the OspB protein appeared to be a doublet (data not shown). This finding suggested the presence of OspB variants in this clonally derived population. To test this hypothesis, a third round of cloning by limiting dilution was carried out. Spirochetes were serially diluted in 10 tubes at each dilution (Fig. 1) . After up to 4 weeks of cultivation, all tubes at the 10-8 dilution, 4 of 10 tubes at the 10-9 dilution (numbers 1, 6, 7, and 10), and no tubes at the 1010 dilution had growth. The cultures in the four 10-9 dilution tubes were designated Vi, V6, V7, and V10. Proteins in total cell lysates of the clones were examined by PAGE (Fig. 2) After noting the antigenic relationship between the 21K protein and OspB, we investigated whether the 21K protein, like OspB, was cleaved from the cells by proteases and, thus, probably at the cell surface (9, 11) . Intact spirochetes treated with trypsin were examined by PAGE and Western blot (Fig. 4) NlaIV, Hinfl, and Sau3A) that had recognition sites within ospB were selected for use. In B31, there is a Scal site in ospB and an EcoRI site in ospA but not in ospB (13) . We noted two ScaI bands and one EcoRI band on Southern blots of B31 and the HB19 derivatives (Fig. 5) Characterization of single-colony clones. Variants Vi, V7, and V10 were plated on a solid medium to isolate clones as single colonies. Colonies visible to the eye formed within 2 to 3 weeks of incubation, but the efficiencies of plating were not greater than 1%. Different colony types were noted on the plates, but there was no apparent correlation between colony phenotype and PAGE protein profile in preliminary studies. Therefore, several colonies from each variant population were picked at random and examined as to their OspB phenotypes with PAGE and monoclonal antibodies. The colonies were inoculated into broth tubes and passaged once before examination. The single-colony clones were designated with the number of the parental variant and a letter, e.g., V7B for clone B from population V7.
Single-colony clones from Vi (VIA through V1J) or V7 (V7A through V7C) had OspB proteins with the same electrophoretic migrations as the OspB proteins of Vi or V7, respectively (data not shown). Four single-colony clones of V10 were examined and were designated V1OA, V1OB, V1OC, and V1OD. Two of these V10 derivatives had phenotypes not seen among other HB19 progeny studied up to that time. The Mrs of the OspB of V10A, V1OB, and V1OC were 33,700, 33,500, and 33,500, respectively (Fig. 6 ). V10A and the V10 parent had OspB proteins of the same apparent sizes. Unlike the other variants examined, V1OD did not appear to produce any detectable OspB. V1OD did, however, have a new protein with an M, of 18,500.
V1OA through V1OD were subjected to Western blot analyses with the OspB-reactive monoclonal antibodies (Fig.  6 ). H614 and H5TS bound the OspB proteins of V10 and V1OA through V10C. H5TS consistently bound less well in repeat blots to the OspB of V1OB or V1OC than to that of VIO VIOA VIOB VIOC VIOD Fig. 2. INFECT. IMMUN. the 21K and 18.5K proteins. The 18.5K protein of V1OD, as well as the OspB of each of the four other clones, was not detectable in the lanes of trypsinized cells by either protein staining or Western blot. This finding indicated that the 18.5K protein was exposed on the surface of the borrelia.
To look for gene rearrangements or deletions in the second group of variants, plasmid DNA from V10, V1OB, and V1OD was digested with RsaI, DraI, and AluI and probed with pTRH46 (Fig. 8) . Restriction fragment length differences among these variants were not found. If a deletion had occurred in the ospB gene of V1OD, it was not detected by Southern blot with these enzymes.
Northern blot analyses. Northern blots were used to determine whether the absence of OspB in V1OD was the result of failure of ospB transcription. If nonexpression of OspB was due to premature termination of transcription of the osp operon, we expected to find that V1OD had a hybridizable transcript that was shorter in length than the corresponding mRNA of the OspB-producing isolates.
For one blot we used as a probe pTRH46, which contains an entire ospB gene and the 3' end of the ospA gene (13, 18) . Both V10 and V1OD had a major transcript of about 2.2 kb (Fig. 9, left) . In this blot, we noted two major and two minor hybridizing bands of shorter lengths in V10 and V1OD (Fig.  9, left) . These additional bands were also present in extracts of the original isolate of HB19 and all other HB19 variants (data not shown).
To determine whether the shorter bands represented transcripts of ospA or ospB or both, the subclones pBBU31 and pBBU34, which contained the 5' end of ospA and the 3' end of ospB, respectively, were used as probes in other Northern blots. There is no sequence similarity between these different regions of the osp genes (13) , and, thus, crosshybridization would not occur. The right side of Fig. 9 shows that both ospA (pBBU31) and ospB (pBBU34) probes hybridized to RNA of V1OD and V10. The ospA probe hybridized to the 2.2-kb transcript and some degraded material in both extracts but not to the two other major mRNA species hybridized by the pTRH46 probe. This and two repeat experiments showed more degraded material in V1OD than V10; the significance of this finding is not known.
The ospB-specific probe, pBBU34, prominently hybridized to the two smaller major mRNAs in addition to the 2.2-kb transcript. In the three Northern blots with the pBBU34 probe of separate RNA preparations, there were differences between V10 and V1OD in the relative amounts of each of the three types of hybridizable mRNA that were detected in each blot. However, these quantitative differences were slight and not consistent, and, as Fig. 9 Previous studies showed that B. burgdorferi isolates from North America and Europe differed in the Mrs and antibody reactivities of their OspA and OspB proteins (8, 9, 30) . Some isolates were found to entirely lack an OspB protein (9, 30) . Schwan and colleagues demonstrated that some populations of B. burgdorferi exhibited changes in OspB proteins during serial passage in vitro (23, 24) . The original spirochete inocula for their experiments were obtained directly from ticks, however, and possibly were mixtures of strains.
Western blot studies of serial sera from patients with Lyme borreliosis who develop chronic arthritis showed that antibody to some B. burgdorferi antigens appeared only after periods of months (3, 17) . Of relevance to the present study VOL. (17) . Accompanying the late anti-OspB response was the new appearance of antibody to 18K to 21K proteins. These results were considered evidence of antigenic variation of OspB (17) .
Conceivably what we took to be HB19 variants were actually contaminants, most likely from B31, the strain which had for long been passaged in parallel with HB19 in our laboratory. This explanation was unlikely, though, for the following reasons. First, the monoclonal antibody H6831, which binds to B31 cells (8, 9) , did not bind to parental HB19 or its derivatives. Second, the Southern blots showed differences between B31 and the HB19 variants in restriction sites both within and without the ospB gene. Third, the banding pattern of total plasmid DNA as revealed by gel electrophoresis was unique for B31 and could be distinguished from the patterns of Vl, V7, and V10 plasmid DNA (2; unpublished observations).
In this study, we did not determine the frequency of variation. The variants appeared in the population of HB19 organisms during the approximately 600 generations that passed from the last date of cloning by limiting dilution. At the start of the present study, there undoubtedly was a mixed population of HB19 variants. The variants included in this and subsequent generations were isolated by the two methods of cloning. Preliminary studies suggest that the OspB mutation rate is less than 10-2 per cell per generation in broth (unpublished observations).
Plating of bacteria on solid medium can provide an estimate of the rate of phase variation in colony type. Initial studies showing colony phenotype differences encouraged us to pursue this line. However, we did not find the correlation between colony phenotype and OspB phenotype to be sufficiently high for colony phenotype to be useful as a marker for OspB variation rate studies. Moreover, such studies would be difficult to interpret given an efficiency of plating that was at most 1%.
The antigenic relatedness between OspB and the 21K and 18.5K proteins was demonstrated with a monoclonal antibody. Increased production of an approximately 20K protein in isolate's without OspB had been shown previously (9, 23, 24) , but antigenic cross-reactivity between OspB and the smaller proteins had not been appreciated. The small amounts of 21K and 18.5K proteins noted in Western blots of variants other than Vl and V1OD may represent heterogeneity of the population or low-level production of these proteins by each cell. Among the variants studied here, increased production of the 21K or 18.5K protein was associated with decreased or halted production of OspB itself.
In trying to understand the mechanism behind OspB antigenic variation, we first looked for DNA rearrangements. In the related Borrelia species, B. hermsii, which switches surface proteins to avoid the immune response of the host during relapsing fever, changes in serotype-specifying proteins are the consequence of the translocation of an antigen-encoding gene from a silent to an expression locus (21, 22 The Southern blots would not necessarily detect singlebase changes in an ospB gene or its flanking sequences. A base substitution or frameshift by the addition or deletion of a base could result in missense or nonsense mutations or in a deleterious alteration in a regulatory sequence, such as the consensus ribosomal binding site between the end of the ospA and start of the ospB genes (13) . These local changes could affect translation of an ospA-ospB transcript not yet manifest as a change in restriction fragment lengths or numbers. In this particular case, the length of the ospA-ospB transcript would also likely be unchanged and could only be detected by nucleotide sequencing of the mRNA or DNA. On the other hand, some mutations involving one or a few bases could alter transcription itself. For example, base substitutions bringing a greater potential for formation of a hairpin in mRNA could result in the stalling of transcription before the RNA polymerase complex had completed the ospB gene. In this situation, we would expect the osp transcript to be shorter in variants lacking OspB than in isolates producing that protein.
To detect the latter types of mutations, we performed Northern blot analyses. These studies did not reveal qualitative differences among the mRNAs of the different variants. The OspB-variant V1OD had a full-length ospA-ospB transcript. Thus, the failure to express OspB by V1OD could not be explained by premature termination of transcription of the ospA-ospB tandem. The significance of the shorter transcripts that were hybridized by the ospB probe but not by the ospA probe is not known. This finding suggests that there is either another transcriptional start in the operon, presumably within the ospA gene, or that degradation occurs first of the 5', i.e., ospA, end of the transcript. The smaller hybridizing mRNAs may encode the 18.5K and 21K proteins. However, the amounts of each of these shorter mRNAs were more or less the same regardless of whether a shorter protein was produced or not.
Another model contends that the shorter proteins are the products of action by an endogenous protease. Changes in the nucleotide sequence may have yielded altered OspB proteins that were more susceptible to proteolytic cleavage. Although 
